Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
PHIBRO ANIMAL HEALTH CORP amended revolving credit of aggregate commitment of $435,000,000 with Coöperatieve Rabobank U.A., New York Branch.
- Instrument
- revolving credit
- Principal
- aggregate commitment of $435,000,000
- Counterparty
- Coöperatieve Rabobank U.A., New York Branch
- Event
- amendment
Exact text from the filing
1, the revolving credit commitment available to the Company under the Original Credit Agreement has increased by $125,000,000, from $310,000,000 to an aggregate commitment of $435,000,000. The foregoing description of Amendment No. 1 does not purport to be complete and is qualified in its entirety by reference to Amendment No. 1, a copy of which has been filed as
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
PHIBRO ANIMAL HEALTH CORP amended Amendment No. 1 with Coöperatieve Rabobank U.A., New York Branch valued at $125,000,000 (effective 2026-04-28).
- Action
- amendment
- Agreement
- credit facility
- Counterparty
- Coöperatieve Rabobank U.A., New York Branch
- Value
- $125,000,000
- Effective
- 2026-04-28
Exact text from the filing
On April 28, 2026, Phibro Animal Health Corporation (the “Company”) entered into Amendment No. 1 to its Credit Agreement (“Amendment No. 1”) with Coöperatieve Rabobank U.A., New York Branch, as administrative agent, collateral agent and L/C issuer, and each lender from time to time party thereto, which amends the Credit Agreement, dated as of July 3, 2024
View on SEC.gov